SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?

被引：9
|
作者：
Simonsen, Anita T. [1 ]
Schou, Marie [1 ]
Sorensen, Camilla D. [1 ]
Bentzen, Hans H. N. [1 ]
Nyvold, Charlotte G. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus C, Denmark
来源：
LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 09期
关键词：
MOLECULAR REMISSION; EXPRESSION; TRANSPLANTATION; PATHOGENESIS; PREDICTOR; T(11/14);
D O I：
10.3109/10428194.2015.1004672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2724 / 2727
页数：4
相关论文
共 50 条
  • [1] SOX11, CCND1, BCL1/Igh, and Igh-VDJ - a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?
    Simonsen, Anita Tranberg
    Schou, Marie
    Sorensen, Camilla Darum
    Hokland, Peter
    Bentzen, Hans
    Nyvold, Charlotte Guldborg
    BLOOD, 2014, 124 (21)
  • [2] A TECHNICAL COMPARISON BETWEEN IGH AND BCL1/IGH MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE ANALYSIS IN MANTLE CELL LYMPHOMA
    Ghione, P.
    Monitillo, L.
    Barbero, D.
    Verardo, G.
    Drandi, D.
    Grimaldi, D.
    Genuardi, E.
    Mantoan, B.
    Cavallo, F.
    Vasta, M.
    Zaja, F.
    Visco, C.
    Cortelazzo, S.
    Boccadoro, M.
    Ladetto, M.
    Ferrero, S.
    HAEMATOLOGICA, 2016, 101 : S43 - S44
  • [3] SOX11 Cooperates with CCND1 in Mantle Cell Lymphoma Pathogenesis
    Kuo, Pei-Yu
    Jiang, Zewei
    Perumal, Deepak
    Leshchenko, Violetta V.
    Lagana, Alessandro
    Katz, Samuel G.
    Walensky, Loren D.
    Shaknovich, Rita
    Ye, B. Hilda
    Parekh, Samir
    BLOOD, 2015, 126 (23)
  • [4] Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies
    Peterson, Jess F.
    Baughn, Linda B.
    Ketterling, Rhett P.
    Pitel, Beth A.
    Smoley, Stephanie A.
    Vasmatzis, George
    Smadbeck, James B.
    Greipp, Patricia T.
    Mangaonkar, Abhishek A.
    Thompson, Carrie A.
    Parikh, Sameer A.
    Chen, Dong
    Viswanatha, David S.
    BLOOD ADVANCES, 2019, 3 (08) : 1298 - 1302
  • [5] SOX11 as a minimal residual disease marker for Mantle cell lymphoma
    Simonsen, Anita Tranberg
    Sorensen, Camilla Darum
    Ebbesen, Lene Hyldahl
    Bodker, Julie Stove
    Bentzen, Hans Herluf Norregaard
    Nyvold, Charlotte Guldborg
    LEUKEMIA RESEARCH, 2014, 38 (08) : 918 - 924
  • [6] Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma
    Mohanty, Atish
    Sandoval, Natalie
    Phan, An
    Nguyen, Thang V.
    Chen, Robert W.
    Budde, Elizabeth
    Mei, Matthew
    Popplewell, Leslie
    Pham, Lan V.
    Kwak, Larry W.
    Weisenburger, Dennis D.
    Rosen, Steven T.
    Chan, Wing C.
    Muschen, Markus
    Ngo, Vu N.
    BLOOD, 2019, 133 (04) : 306 - 318
  • [7] Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14
    Aventín, A
    Nomdedéu, J
    Briones, J
    Espinosa, I
    Bordes, R
    Sierra, J
    JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (10) : 798 - 800
  • [8] Blastoid Variant Mantle Cell Lymphoma with Amplified IGH/CCND1 Fusion: A Unique Case and Current Literature Review
    Goktas, Emine
    Sanal, Sumeyye
    Esen, Haci Hasan
    Tekinalp, Atakan
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2024, 62 (02): : 124 - 127
  • [9] SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis
    Meggendorfer, M.
    Kern, W.
    Haferlach, C.
    Haferlach, T.
    Schnittger, S.
    LEUKEMIA, 2013, 27 (12) : 2388 - 2391
  • [10] SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis
    M Meggendorfer
    W Kern
    C Haferlach
    T Haferlach
    S Schnittger
    Leukemia, 2013, 27 : 2388 - 2391
12345